We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

AI-Guided Handheld Surgical Robot Can Stem Fatal Blood Loss

By HospiMedica International staff writers
Posted on 21 Mar 2022
Print article
Image: The AI-Guided Ultrasound Intervention Device can halt rapid blood loss (Photo courtesy of MIT)
Image: The AI-Guided Ultrasound Intervention Device can halt rapid blood loss (Photo courtesy of MIT)

After a traumatic accident, there is a small window of time when medical professionals can apply lifesaving treatment to victims with severe internal bleeding. Delivering this type of care is complex, and key interventions require inserting a needle and catheter into a central blood vessel, through which fluids, medications, or other aids can be given. Researchers have developed a lifesaving technology that helps a range of users deliver complex medical interventions at the point of injury.

A team of researchers at the Massachusetts Institute of Technology (MIT, Cambridge, MA, USA) and physicians at Massachusetts General Hospital (MGH, Boston, MA, USA) have developed a solution to this problem. The Artificial Intelligence–Guided Ultrasound Intervention Device (AI-GUIDE) is a handheld platform technology that has the potential to help personnel with simple training to quickly install a catheter into a common femoral vessel, enabling rapid treatment at the point of injury.

AI-GUIDE is a platform device made of custom-built algorithms and integrated robotics that could pair with most commercial portable ultrasound devices. To operate AI-GUIDE, a user first places it on the patient’s body, near where the thigh meets the abdomen. A simple targeting display guides the user to the correct location and then instructs them to pull a trigger, which precisely inserts the needle into the vessel. The device verifies that the needle has penetrated the blood vessel, and then prompts the user to advance an integrated guidewire, a thin wire inserted into the body to guide a larger instrument, such as a catheter, into a vessel. The user then manually advances a catheter. Once the catheter is securely in the blood vessel, the device withdraws the needle and the user can remove the device. With the catheter safely inside the vessel, responders can then deliver fluid, medicine, or other interventions.

The MIT researchers developed the AI in the device by leveraging technology used for real-time object detection in images. These algorithms trained on a large dataset of ultrasound scans interpret the visual data coming in from the ultrasound that is paired with AI-GUIDE and then indicate the correct blood vessel location to the user on the display. For the user, the device may seem as easy to use as pressing a button to advance a needle, but to ensure rapid and reliable success, a lot is happening behind the scenes. For example, when a patient has lost a large volume of blood and becomes hypotensive, veins that would typically be round and full of blood become flat. When the needle tip reaches the center of the vein, the wall of the vein is likely to “tent” inward, rather than being punctured by the needle. As a result, though the needle was injected to the proper location, it fails to enter the vessel. To ensure that the needle reliably punctures the vessel, the team engineered the device to be able to check its own work.

AI-GUIDE has shown very high injection success rates, even in hypotensive scenarios where veins are likely to tent. Users with medical experience ranging from zero to greater than 15 years tested AI-GUIDE on an artificial model of human tissue and blood vessels and one expert user tested it on a series of live, sedated pigs. The team reported that after only two minutes of verbal training, all users of the device on the artificial human tissue were successful in placing a needle, with all but one completing the task in less than one minute. The expert user was also successful in quickly placing both the needle and the integrated guidewire and catheter in about a minute. The needle insertion speed and accuracy were comparable to that of experienced clinicians operating in hospital environments on human patients. AI-GUIDE’s design makes it stable and easy to use, directly translates to low training requirements and effective performance. Right now, the team is continuing to test the device and work on fully automating every step of its operation. In particular, they want to automate the guidewire and catheter insertion steps to further reduce risk of user error or potential for infection.

“AI-GUIDE has the potential to be faster, more precise, safer, and require less training than current manual image-guided needle placement procedures,” said Theodore Pierce, a radiologist and collaborator from MGH. “The modular design also permits easy adaptation to a variety of clinical scenarios beyond vascular access, including minimally invasive surgery, image-guided biopsy, and imaging-directed cancer therapy.”

“We see the AI-GUIDE platform technology becoming ubiquitous throughout the health-care system, enabling faster and more accurate treatment by users with a broad range of expertise, for both pre-hospital emergency interventions and routine image-guided procedures,” said Matt Johnson, a research team member from the MIT laboratory’s Human Health and Performance Systems Group.

Related Links:
MIT
MGH 

Gold Supplier
Ultrasound Transducer/Probe Cleaner
Transeptic Cleaning Solution
New
Vital Signs Monitor
VSM – 300C
New
Robotic Knee Replacement System
ROSA Knee
New
Single-Use Video Laryngoscope
GlideScope Spectrum

Print article
Radcal

Channels

AI

view channel
Image: The WHO has conditionally recommended the use of algorithms in assisting with pediatric tuberculosis diagnosis (Photo courtesy of Pexels)

New Evidence-Based Algorithms Could Improve Diagnosis of Pediatric Tuberculosis

Tuberculosis (TB) continues to be one of the most prevalent causes of death among younger populations worldwide. Research indicates that over 96% of the deadly TB cases in children under the age of 15... Read more

Health IT

view channel
Image: Using digital data can improve health outcomes (Photo courtesy of Unsplash)

Electronic Health Records May Be Key to Improving Patient Care, Study Finds

When a patient gets transferred from a hospital to a nearby specialist or rehabilitation facility, it is often difficult for personnel at the new facility to access the patient’s electronic health records... Read more

Business

view channel
Image: The demand for endometrial ablation devices is increasing due to rising prevalence of gynecological disorders (Photo courtesy of Pexels)

Global Endometrial Ablation Market Driven by Rising Prevalence of Gynecological Disorders

Gynecological disorders, such as menorrhagia, PCOD, abnormal vaginal bleeding, affect millions of women globally every year and are on the rise. Abnormal Uterine Bleeding (AUB) is the most common disorder... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.